Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 281

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 281
---
 of provisions to be inapplicable or unenforceable. Exchange Listing Our Common Stock and Public Warrants are listed on the Nasdaq Capital Market under the symbol “CERO” and “CEROW,” respectively. Transfer Agent and Registrar The transfer agent and registrar for our securities is Continental Stock Transfer & Trust Company. The transfer agent and registrar’s address is One State Street Plaza, 30 thFloor, New York, New York 10004, and its telephone number is (800) 509-5586. 178 DESCRIPTION OF SECURITIES WE ARE OFFERING We are offering up to 4.000,000 shares of our Common Stock or Pre-Funded Warrants to purchase up to 4,000,000 shares of our Common Stock together with up to 4,000,000 Offered Common Warrants to purchase up to 4,000,000 shares of Common Stock. For each Pre-Funded Warrant we sell, the number of shares of Common Stock we are offering will be decreased on a one-for-one basis. Each share of Common Stock or Pre-Funded Warrant is being sold together with an Offered Common Warrant to purchase one share of Common Stock. The shares of Common Stock or Pre-Funded Warrants and accompanying Offered Common Warrants will be issued separately and will be immediately separable upon issuance but must be purchased together in this offering. We are also registering the shares of Common Stock issuable from time to time upon exercise of the Offered Common Warrants and Pre-Funded Warrants offered hereby. Common Stock The material terms and provisions of our Common Stock are described under the caption “Description of Securities” in this prospectus and are incorporated herein by reference. Pre-Funded Warrants The following summary of certain terms and provisions of the Pre-Funded Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the Pre-Funded Warrant, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of Pre-Funded Warrant for a complete description of the terms and conditions of the Pre-Funded Warrants. Duration and Exercise Price Each Pre-Funded Warrant offered hereby will have an initial exercise price per share equal to $0.001. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until the Pre-Funded Warrants are exercised in full